The trial was conducted in Poland in 2011 and included 1,135 women carrying the breast cancer-associated mutation BRCA1. The final analysis was found on 105 incident cases and showed no decreased cancer risk by selenium supplementation [7]. Here, BRCA1 is linked to breast carcinoma.